The Scope of Things
by Clinical Research News
Episode: 56 - The Clinical Trial Site of 2035
About this podcast
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
Episodes
The newest 20 of 57 episodes
- Episode: 56 - The Clinical Trial Site of 2035 · 50 min · Season 1 Episode 56Imagine walking into a clinical research site in 2035. Do you see a fully virtual, site-less world, or something more grounded and human? On the latest episode of the Scope of…
- Episode: 55 - A Terminal Prognosis Sparks A New Model For Neurology Clinical Research · 46 min · Season 1 Episode 55In this month’s episode of the Scope of Things, we share an episode of a sister podcast, Breaking Health. Breaking Health host Michelle Snyder traces Sandra Abravaya’s path from…
- Episode: 54 - Ken Getz and Rick Ward on Why Source Preparation Delays Clinical Trials · 49 min · Season 1 Episode 54There is a startup delay that often goes undetected: source preparation. Ken Getz, executive director at the Tufts Center for the Study of Drug Development, and Rick Ward, chief…
- Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion · 18 min · Season 1 Episode 53With increasing efforts to scale into international markets, what can we expect from China's drug development industry? Joining the podcast is Daphne Smyth, head of global…
- Episode: 52 - Raj Indupuri on Adoption Hurdles with AI Agents · 25 min · Season 1 Episode 52Clinical trial support companies are rapidly adopting AI, but sponsors have been more hesitant. Raj Indupuri, CEO of eClinical Solutions, gives the top three reasons behind the…
- Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr. · 25 min · Season 1 Episode 51Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why…
- Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works · 40 min · Season 1 Episode 50Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc…
- Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030 · 32 min · Season 1 Episode 49What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to…
- Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials · 23 min · Season 1 Episode 48How can electronic capture of clinical outcome assessments (eCOA) help with the unique challenges of pediatric rare disease trials? Florence Mowlem, chief scientific officer of…
- Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems · 25 min · Season 1 Episode 47Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma…
- Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game · 26 min · Season 1 Episode 46Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host Deborah…
- Episode: 45 - Doug Bain on Streamlining Clinical Trials · 24 min · Season 1 Episode 45Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast. With…
- Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs · 16 min · Season 1 Episode 44This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executives…
- Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn · 24 min · Season 1 Episode 43For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offers…
- Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael · 28 min · Season 1 Episode 42Joseph Mikhael, chief medical officer of The International Myeloma Foundation, and his organization are pulling all the stops to find a true cure for multiple myeloma, a rare and…
- Episode: 41 - How Non-Profits Are Filling Unique Roles in Clinical Research · 35 min · Season 1 Episode 41Children’s Tumor Foundation CEO Annette Bakker discusses what non-profit organizations uniquely bring to clinical research and new financial models sustaining their contribution…
- Episode 40: The Advancement and Implementation of Pragmatic Trials · 28 min · Season 1 Episode 40The latest on a trio of pragmatic trials for lung cancer treatment, the implementation of national-scale pharmacogenomic testing, an efficient approach to comparing commonly used…
- Episode: 39 - Blythe Adamson on Patient-Level Real-World Data for Multinational Oncology Research · 26 min · Season 1 Episode 39In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selection for…
- Episode: 38 - Tackling the Misinformation Epidemic with Briony · 20 min · Season 1 Episode 38In this episode of the Scope of Things, host Deborah Borfitz brings you the news on a precision medicine initiative in Sweden integrating research with healthcare, newly…
- Episode: 37 - Using AI to Translate Clinical Trial Results with Ravi Parikh · 25 min · Season 1 Episode 37In this episode of The Scope of Things, host Deborah Borfitz covers the latest news, including setting expectations for Phase II cancer trials, key learnings about dementia from…







